An antithrombotic recombinant batroxobin lyophilized preparation

The technology of freeze-dried preparation and batroxobin is applied in the field of antithrombotic drugs, which can solve problems such as proteins with complex sugar chains in spatial structure, and achieve the effects of reducing storage and transportation costs, improving stability and enhancing safety.

Active Publication Date: 2011-11-30
GRAND LIFE SCI (LIAONING) CO LTD
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, proteins with complex spatial structures and sugar chains are not suitable for expression in prokaryotic cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • An antithrombotic recombinant batroxobin lyophilized preparation
  • An antithrombotic recombinant batroxobin lyophilized preparation
  • An antithrombotic recombinant batroxobin lyophilized preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] According to the Bothrops atrox genus disclosed in U.S. Genebank, the nucleotide sequence (Itoh N, Tanaka N, Mihashi S, Yamashina L, Molecular Cloning and Sequence Analysis of cDNA for Batroxobin, aThrombin-like Snake) of batroxobin (X12747) of moojeni venom species Venom Enzyme, J Biol Chem.1987 Mar5; 262 (7): 3132-5), select the genetic code of yeast preference, artificially synthesize the structural gene sequence of the site-specific transformation of batroxobin, and encode the 45th Arg The code AGA is mutated into AAG encoding Lys, and the endogenous KEX2 protease recognition sequence Arg-Arg of yeast is mutated into Arg-Lys, so KEX2 protease will not degrade the batroxobin secreted into the fermentation broth at this site, thereby making The target protein can accumulate in large quantities. In order to recombine the synthetic target gene into the yeast secretory expression vector pPICZα, an Xho I restriction site was added to the 5' end of the gene, and a stop cod...

Embodiment 2

[0077] Linearize pPICZα-Bg with DNA restriction endonuclease SacI, prepare yeast host competent and transform according to the method in Multi-Copy Pichia Expression Kit Version B of Invitrogen Company, and spread the transformed cells on YPD+500ug / ml It grows on Zeocin medium, and a single colony can appear after 3-4 days at 30°C. Clones with large and full colonies were selected for expression screening.

Embodiment 3

[0079] The high-expression engineered bacteria screened in test tubes were inoculated into shake flasks for proliferation as seed liquid, and then transferred to a 30L fermenter for pilot-scale fermentation according to the conventional method of methanol yeast fermentation. Induced for more than 200 hours. When the protein activity in the fermentation broth no longer increased, the fermentation broth was centrifuged to collect the supernatant, and the protein activity reached 84KU / ml. After microfiltration and sterilization, the active protein with a purity of more than 97% is obtained by using hydrophobic column chromatography, ion exchange column chromatography, gel column chromatography and other biochemical separation techniques.

[0080] The method for measuring the activity of similar products was used for the in vitro coagulation test. The specific test method was as follows: take 0.2ml of human-citrate anticoagulant plasma, add it to a test tube with a diameter of 1cm...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The object of the present invention is to provide a kind of antithrombotic recombinant batroxobin lyophilized preparation, it is characterized in that: this preparation contains recombinant site-directed mutation batroxobin, excipient and lyoprotectant, its ratio is, batroxobin: Excipient: protective agent = 10BU: 10-100 mg: 0.1-5 mg, preferably batroxobin: excipient: protective agent = 10BU: 30-70 mg: 1-4 mg. The freeze-dried preparation has stable activity, is safe and effective, saves cost, and is convenient for transportation and storage.

Description

technical field [0001] The invention relates to antithrombotic drugs, and in particular provides an antithrombotic recombinant batroxobin freeze-dried preparation. Background technique: [0002] With the increase of patients with thromboembolic diseases, the development of antithrombotic drugs has become one of the hot spots. On the one hand, people use molecular biology techniques to modify the molecular structure of existing drugs in order to obtain better thrombolytic drugs. On the other hand, we are actively looking for some natural thrombolytic drugs with good safety, good curative effect and few side effects. [0003] Snake venom is a mixture containing a variety of biologically active proteins and polypeptides, and contains a variety of antithrombotic components. Since the 1960s, people have successively developed some snake venom preparations with antithrombotic effect: in 1976, Esnouf purified thrombin-like enzymes or thrombin-like Enzymes (TLEs) from the venom of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/19A61K38/48C12N1/19C12N9/60C12N15/81A61P7/02C12R1/84
Inventor薛百忠王宏英薛雁徐梅王建华姜大威杨宇孟威段威
OwnerGRAND LIFE SCI (LIAONING) CO LTD